Page 90 - 《中国药房》2025年9期
P. 90

heparins  and  heparinoids[J].  Thromb  Haemost,2007,97  cesarean  delivery  in  a  patient  receiving  fondaparinux[J].
              (3):496-497.                                         Ochsner J,2011,11(1):81-83.
          [13]  CIURZYŃSKI M,JANKOWSKI K,PIETRZAK B,et al.    [25]  LINNEMANN B,SCHOLZ U,ROTT H,et al. Treatment
               Use of fondaparinux in a pregnant woman with pulmonary   of pregnancy-associated venous thromboembolism-position
               embolism and heparin-induced thrombocytopenia[J]. Med   paper from the Working Group in Women’s Health of the
               Sci Monit,2011,17(5):CS56-CS59.                     Society of Thrombosis and Haemostasis (GTH)[J]. Vasa,
          [14]  KNOL  H  M,SCHULTINGE  L,ERWICH  J  M,et  al.      2016,45(2):103-118.
               Fondaparinux  as  an  alternative  anticoagulant  therapy      [26]  BUTWICK A J,CARVALHO B. Neuraxial anesthesia in
               during  pregnancy[J].  J Thromb  Haemost,2010,8(8):  obstetric  patients  receiving  anticoagulant  and  antithrom‐
               1876-1879.                                          botic drugs[J]. Int J Obstet Anesth,2010,19(2):193-201.
          [15]  MAZZOLAI  L,HOHLFELD  P,SPERTINI  F,et  al.   [27]  CROWTHER M A,WARKENTIN T E. Bleeding risk and
               Fondaparinux is a safe alternative in case of heparin into-   the management of bleeding complications in patients un‐
               lerance during pregnancy[J]. Blood,2006,108(5):1569-  dergoing  anticoagulant  therapy:focus  on  new  anticoagu‐
               1570.                                               lant agents[J]. Blood,2008,111(10):4871-4879.
          [16]  MAUERMANN  E,VÖKT  C,TSAKIRIS  D  A,et  al.   [28]  EUGIA US LLC. Fondaparinux sodium-fondaparinux so‐
               Heparin-induced thrombocytopenia in pregnancy:an inter‐  dium  injection,solution[EB/OL].  [2024-09-20].  https://
               disciplinary challenge:a case report and literature review  www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=
               [J]. Int J Obstet Anesth,2016,26:79-82.             overview.process&ApplNo=206918.
          [17]  DINDINGER R,MULLA B M,STUCKY C. Case report   [29]  PETERSEN  S  R,BONNESEN  K,GROVE  E  L,et  al.
               of umbilical artery thrombosis in a patient with a history   Bleeding risk using non-steroidal anti-inflammatory drugs
               of  heparin-induced  thrombocytopenia[J].  J  Obstet  Gyne‐  with anticoagulants after venous thromboembolism:a na‐
               col Neonatal Nurs,2023,52(6):501-508.               tionwide Danish study[J]. Eur Heart J,2025,46(1):58-68.
          [18]  WIJESIRIWARDANA  A,LEES  D  A  R,LUSH  C.     [30]  GARCIA D A,BAGLIN T P,WEITZ J I,et al. Parenteral
               Fondaparinux as anticoagulant in a pregnant woman with   anticoagulants:antithrombotic  therapy  and  prevention  of
               heparin  allergy[J].  Blood  Coagul  Fibrinolysis,2006,17  thrombosis,9th  Ed:American  College  of  Chest  Physi‐
              (2):147-149.                                         cians  evidence-based  clinical  practice  guidelines[J].
          [19]  BUONOMO A,NUCERA  E,DE  CAROLIS  S,et  al. A       Chest,2012,141(Suppl. 2):e24S-e43S.
               case  of  heparin  allergy  with  good  tolerability  to   [31]  BABIN  J  L,TRAYLOR  K  L,WITT  D  M.  Laboratory
               fondaparinux  during  pregnancy[J].  J  Investig  Allergol   monitoring   of   low-molecular-weight   heparin   and
               Clin Immunol,2015,25(3):229-231.                    fondaparinux[J].  Semin  Thromb  Hemost,2017,43(3):
          [20]  HIME N,AUCHET T,GUERCI P,et al. Vaginal delivery   261-269.
               in a parturient excessively anticoagulated with fondaparinux  [32]  PAOLUCCI  F,CLAVIÉS  M  C,DONAT  F,et  al.
               [J]. Int J Obstet Anesth,2012,21(4):385-387.        Fondaparinux sodium mechanism of action:identification
          [21]  LOVATT C A,CROWTHER M A. Challenging anticoagu‐    of specific binding to purified and human plasma-derived
               lation cases:a case of heparin-induced-thrombocytopenia   proteins[J].  Clin  Pharmacokinet,2002,41(Suppl.  2):
               in the first trimester of pregnancy[J]. Thromb Res,2021,  11-18.
               207:58-61.                                     [33]  BAUER  K A.  Fondaparinux:dosing  and  adverse  effects
          [22]  HARUTA S,MARUTA K,NAKAJIMA Y,et al. Use of         [EB/OL].(2023-07-25)[2024-09-15].  https://www. upto‐
               fondaparinux for thromboprophylaxis in an unfractionated   date.cn/contents/zh-Hans/fondaparinux-dosing-and-adverse-
               heparin-intolerant  pregnant  woman  with  thrombotic  pre‐  effects?search=Fondaparinux&source=search_result&se‐
               disposition[J].  J  Obstet  Gynaecol  Res,2017,43(5):  lectedTitle=1%7E69&usage_type=default&display_rank=1.
               943-945.                                       [34]  赖宇尧,李桂珊,王志明,等. 抗Ⅹa活性检测在抗凝药物
          [23]  EKBATANI A,ASARO L R,MALINOW A M. Anticoa-         监测中的应用[J]. 标记免疫分析与临床,2020,27(8):
               gulation  with  argatroban  in  a  parturient  with  heparin-  1444-1449.
               induced thrombocytopenia[J]. Int J Obstet Anesth,2010,       (收稿日期:2024-12-25  修回日期:2025-04-21)
               19(1):82-87.                                                                       (编辑:胡晓霖)
          [24]  RENTZ J B,HART S R,RUSSO M. Spinal anesthesia for





          · 1104 ·    China Pharmacy  2025 Vol. 36  No. 9                              中国药房  2025年第36卷第9期
   85   86   87   88   89   90   91   92   93   94   95